Weill Cornell MedicineJul 25 2024 Two Medicaid policies can interact to increase oncology clinical trial enrollment among Black and Hispanic patients, according to a new study by investigators at Weill Cornell Medicine, the University of Pennsylvania, and Medidata AI.
The study team analyzed deidentified national enrollment data for nearly 50,000 participants in cancer clinical trials from 2012 to 2019 from Medidata's Rave electronic data capture archives. During the study period, only 12 states and the District of Columbia mandated Medicaid coverage of clinical trial costs.
Dr. William L. Schpero, co-lead author, assistant professor of population health sciences at Weill Cornell Medicine "The headline here is that Medicaid expansion by itself did not improve cancer clinical trial diversity; we only saw improvement in those states that already mandated coverage of the routine costs of clinical trial participation," said co-lead author Dr. Samuel U. Takvorian, an assistant professor of hematology-oncology in the Perelman School of Medicine at the University of Pennsylvania.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: medical_xpress - 🏆 101. / 51 Read more »